Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: A study of 121 patients

Blood

Volumn 98, Issue 6, 2001, Pages 1847-1851

  Müller, Susanna M ^a   Ege, Markus ^a   Pottharst, Annette ^a   Schulz, Ansgar S ^a   Schwarz, Klaus ^a   Friedrich, Wilhelm ^a,b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGENIC AGENT;

ARTICLE; CELL FUNCTION; CHIMERA; CLINICAL FEATURE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HLA TYPING; HUMAN; HUMAN CELL; INFANT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SKIN MANIFESTATION; T LYMPHOCYTE;

EID: 0035885937     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.6.1847     Document Type: Article

References (15)

1. Rosen FS, Cooper MD, Wedgewood RJP. The primary immunodeficiencies. N Engl J Med. 1995;333:431-440.
2. Kadowaki JI, Zuelzer WW, Brough AJ, Thompson RL, Wooley PV, Gruber D. XX/XY lymphoid chimerism in congenital immunological deficiency syndrome with thymic alymphoplasia. Lancet. 1965;1152-1155.
3. Pollack MS, Kirkpatrick D, Kapoor N, Dupont B, O'Reilly RJ. Identification of intrauterine-derived maternal T-cells in four patients with severe combined immunodeficiency. N Engl J Med. 1982;11:662-666.
4. Flomenberg N, Dupont B, O'Reilly RJ, Hayward A, Pollack M. The use of T cell culture techniques to establish the presence of an intrauterine derived maternal T-cell graft in a patient with severe combined immunodeficiency (SCID). Transplantation. 1993;36:733-735.
5. Conley ME, Nowell PC, Henle G, Douglas SD. XX T-cells and XY B-cells in two patients with severe combined immune deficiency. Clin Immunol Immunopathol. 1984;31:87-95.
6. Geha R, Reinherz E. Identification of maternal T and B lymphocytes in uncomplicated severe combined immunodeficiency by HLA typing of subpopulations of T-cells separated by the fluorescence-activated cell sorter and of Epstein-Barr virus derived B cell lines. J Immunol. 1983;130:2493-2530.
7. Anderson KC, Weinstein HJ. Transfusion-associated graft-versus-host-disease. N Engl J Med. 1990;5:315-321.
8. Thompson LF, O'Connor RD, Bastian JF Phenotype and function of engrafted maternal T-cells in patients with severe combined immunodeficiency. J Immunol. 1984;135:2513-2517.
9. Wahn V, Yokota S, Meyer KL, et al. Expansion of a maternally derived monoclonal T cell population with CD3+/CDS+/T cell receptor-gamma/delta+ phenotype in a child with severe combined immunodeficiency. J Immunol. 1991;147:2934-2941.
10. Knobloch C, Goldmann SF, Friedrich W. Limited T cell receptor diversity of transplacentally acquired maternal T-cells in severe combined immunodeficiency. J Immunol. 1991;146:4157-4164.
11. Vartdal F, Bratlin A, Gauderneck G, et al. Microcytoxic HLA typing of cells directly isolated from blood by means of antibody-coated microspheres. Transplant Proc. 1987;19:655-657.
12. Sottini A, Quiros-Roldan E, Notarangelo LD, Malagoli A, Primi D, Imberti L. Engrafted maternal T-cells in severe combined immunodeficiency patient express T-cell receptor variable beta segments characterized by a restricted V-D-J junctional diversity. Blood. 1995;85:2105-2113.
13. Lo Y, Lo ESF, Watson N, et al. Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood. 1996;88:4390-4395.
14. Lo Y, Lau T, Chan L, Leung T, Chang A. Quantitative analysis of the bi-directional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem. 2000;46:1301-1309.
15. Scaradavou A, Carrier C, Mollen N, Stevens C, Rubinstein P. Detection of maternal DNA in placental/umbilical cord blood by locus-specific amyplification of the noninherited maternal HLA gene. Blood. 1996;88:1494-1500.